NCT00207337View on ClinicalTrials.gov

Exhale (R) Stent for Emphysema

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

July 31, 2004

Primary Completion Date

May 31, 2006

Study Completion Date

May 31, 2006

Conditions
Emphysema
Interventions
DEVICE

Exhale Drug-Eluting Stent

Trial Locations (6)

2134

Concord Repatriation General Hospital, Burwood

3181

The Alfred Hospital, Prahran

4032

The Prince Charles Hospital, Rode Road, Chermside

30625

Medizinische Hochschule Hannover, Hanover

66421

Universitätsklinik des Saarlandes, Homburg

90020-090

Irmandade Santa Casa de Misericordia, Porto Alegre

Sponsors
All Listed Sponsors
lead

Broncus Technologies

INDUSTRY

NCT00207337 - Exhale (R) Stent for Emphysema | Biotech Hunter | Biotech Hunter